Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03670524 · ClinicalTrials.gov registry record · NA
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
A NA study of Cardiovascular Diseases and Metabolic Health, sponsored by University of Louisville.
- Recruiting
- Registry status
- NA
- Development phase
- 835
- Enrollment target
- 1
- Study location
NCT03670524: Recruiting NA study of Cardiovascular Diseases and Metabolic Health, sponsored by University of Louisville.
NCT03670524 is a NA study of Cardiovascular Diseases and Metabolic Health that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 835 participants, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03670524, a NA study of Cardiovascular Diseases and Metabolic Health, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- NA
- Development phase
- 835 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine how the environment and neighborhood characteristics affects the health of the area residents. The study will help determine how changing neighborhood characteristics, such as green space, affect heart health, risk factors for other diseases, sense of well- being or neighborhood cohesion.
Primary Outcome
Augmentation index-percent
Conditions Studied
Interventions
- OTHER Greenness as a therapeutic intervention
Study Locations (1)
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 835 participants |
| Start Date | 2018-05-03 |
| Est. Completion | 2028-10-30 |
| Phase | NA |
What NCT03670524 shows while recruiting
NCT03670524 is an interventional study that assigns participants to a tested intervention. The registered 835 participants enrollment target is mid-sized for trials with a published cap, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Greenness as a therapeutic intervention is the first listed.
NCT03670524 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT03670524 about?
NCT03670524 is a clinical study titled "Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project". The purpose of this study is to examine how the environment and neighborhood characteristics affects the health of the area residents. The study will help determine how changing neighborhood characteristics, such as green space, affect heart health, risk factors for other diseases, sense of well- be...
What is the current status of trial NCT03670524?
This trial is currently recruiting. It is a NA study. The enrollment target is 835 participants. The study started on 2018-05-03. Estimated completion is 2028-10-30.
What conditions does trial NCT03670524 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Metabolic Health.
What interventions are being tested in trial NCT03670524?
The interventions under investigation include: Greenness as a therapeutic intervention (OTHER).
Who is sponsoring clinical trial NCT03670524?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03670524 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03670524's enrollment target sits among peer trials
835 67th of 300 higher than 234 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118467 · 836 participants · Phase 4
Vasoactive Drugs in Intensive Care Unit
- NCT02422550 · 837 participants
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
- NCT06910553 · 832 participants
IBD Pregnancy Registry
- NCT07089706 · 832 participants · Phase 4
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI